Trade ATYR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
aTyr Pharma, Inc. (ATYR) is trading at US$0.20, down 2.54% today as of Oct 14, 11:58 EDT. The company has a market capitalisation of US$49.19M. Over the past 52 weeks, ATYR has traded between US$0.20 and US$1.11. On Syfe you can trade ATYR with $0 commission and add it to your watchlist.
| Previous close | US$0.20 |
|---|---|
| Market cap | US$49.19M |
| 52-week range | US$0.20 – US$1.11 |
| Volume | 2.63M |
| Exchange | US |
aTyr Pharma, Inc.
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Year: 2015
aTyr Pharma Updates Timing of FDA Response for Planned Phase 3 Trial of Efzofitimod
Sep 1, 9:10 PM · MT Newswires
Update: ATyr Pharma Fiscal Q2 Loss Narrows; Announces Restructuring Plans
Aug 7, 8:39 PM · MT Newswires
ATyr Pharma Fiscal Q2 Loss Narrows
Aug 7, 8:14 PM · MT Newswires
aTyr Pharma, Inc. (ATYR) stock is trading at US$0.20, -2.54% from the previous close of US$0.20.
The market cap for aTyr Pharma, Inc. (ATYR) stock is approximately US$49.19M.
The 52-week high for aTyr Pharma, Inc. (ATYR) stock is US$1.11.
The 52-week low for aTyr Pharma, Inc. (ATYR) stock is US$0.20.
aTyr Pharma, Inc. (ATYR) does not currently pay a dividend.
Stay on top of ATYR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
